<p xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:oasis="http://www.niso.org/standards/z39-96/ns/oasis-exchange/table" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:bkstg="http://www.atypon.com/backstage-ns">Baseline characteristics of participants with eGFR &lt;45, 45 to &lt;60, 60 to &lt;90, and ≥90 mL/min/1.73 m<sup>2</sup> are presented in <a class="ref showTableEvent" data-id="T1" href="#T1">Table 1</a>.
 In progressively lower categories of eGFR, participants were older and 
more likely to be female; be white; have a longer duration of diabetes; 
have established micro- or macrovascular disease; have a history of 
heart failure, micro- or macroalbuminuria; and be treated with insulin 
and cardiovascular protective therapies (all <i>P</i>&lt;0.0001). 
Baseline characteristics for participants with and without CKD were well
 balanced across randomized groups and have been previously published.<sup><a data-tab="pane-pcw-references" href="#R15" id="R15R" class="tab-link">15</a></sup></p>
<div id="T1" class="anchor-spacer"></div>
<div class="article-table-content" id="T1">
<table class="table article-section__table">
<caption><strong><p xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:oasis="http://www.niso.org/standards/z39-96/ns/oasis-exchange/table" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:bkstg="http://www.atypon.com/backstage-ns"><strong class="captionLabel">Table 1.</strong> Characteristics of Participants With eGFR &lt;45, 45 to &lt;60, 60 to &lt;90, and ≥90 mL/min/1.73 m<sup>2</sup> at Baseline<a class="ref showTableEvent" data-id="tab1fn2" href="#tab1fn2">*</a></p></strong></caption>
<thead xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:oasis="http://www.niso.org/standards/z39-96/ns/oasis-exchange/table" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:bkstg="http://www.atypon.com/backstage-ns"><tr>
<th colspan="1" rowspan="1" align="left"></th>
<th colspan="1" rowspan="1" align="center">eGFR &lt;45 mL/min/1.73 m<sup>2</sup> (N = 554)</th>
<th colspan="1" rowspan="1" align="center">eGFR 45 to &lt;60 mL/min/1.73 m<sup>2</sup> (N = 1485)</th>
<th colspan="1" rowspan="1" align="center">eGFR 60 to &lt;90 mL/min/1.73 m<sup>2</sup> (N = 5625)</th>
<th colspan="1" rowspan="1" align="center">eGFR ≥90 mL/min/1.73 m<sup>2</sup> (N = 2476)</th>
</tr></thead>
<tbody xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:oasis="http://www.niso.org/standards/z39-96/ns/oasis-exchange/table" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:bkstg="http://www.atypon.com/backstage-ns">
<tr>
<td colspan="1" rowspan="1" align="left">Age, y, mean (SD)</td>
<td colspan="1" rowspan="1" align="center">68.7 (8.0)</td>
<td colspan="1" rowspan="1" align="center">67.2 (7.6)</td>
<td colspan="1" rowspan="1" align="center">63.6 (7.6)</td>
<td colspan="1" rowspan="1" align="center">59.0 (7.9)</td>
</tr>
<tr><td colspan="5" rowspan="1" align="left">Sex, No. (%)</td></tr>
<tr>
<td colspan="1" rowspan="1" align="left"> Male</td>
<td colspan="1" rowspan="1" align="center">309 (55.8)</td>
<td colspan="1" rowspan="1" align="center">877 (59.1)</td>
<td colspan="1" rowspan="1" align="center">3674 (65.3)</td>
<td colspan="1" rowspan="1" align="center">1648 (66.6)</td>
</tr>
<tr>
<td colspan="1" rowspan="1" align="left"> Female</td>
<td colspan="1" rowspan="1" align="center">245 (44.2)</td>
<td colspan="1" rowspan="1" align="center">608 (40.9)</td>
<td colspan="1" rowspan="1" align="center">1951 (34.7)</td>
<td colspan="1" rowspan="1" align="center">828 (33.4)</td>
</tr>
<tr><td colspan="5" rowspan="1" align="left">Race, No. (%)</td></tr>
<tr>
<td colspan="1" rowspan="1" align="left"> White</td>
<td colspan="1" rowspan="1" align="center">461 (83.2)</td>
<td colspan="1" rowspan="1" align="center">1212 (81.6)</td>
<td colspan="1" rowspan="1" align="center">4475 (79.6)</td>
<td colspan="1" rowspan="1" align="center">1794 (72.5)</td>
</tr>
<tr>
<td colspan="1" rowspan="1" align="left"> Asian</td>
<td colspan="1" rowspan="1" align="center">53 (9.6)</td>
<td colspan="1" rowspan="1" align="center">163 (11.0)</td>
<td colspan="1" rowspan="1" align="center">716 (12.7)</td>
<td colspan="1" rowspan="1" align="center">352 (14.2)</td>
</tr>
<tr>
<td colspan="1" rowspan="1" align="left"> Black or African American</td>
<td colspan="1" rowspan="1" align="center">16 (2.9)</td>
<td colspan="1" rowspan="1" align="center">30 (2.0)</td>
<td colspan="1" rowspan="1" align="center">137 (2.4)</td>
<td colspan="1" rowspan="1" align="center">153 (6.2)</td>
</tr>
<tr>
<td colspan="1" rowspan="1" align="left"> Other<a class="ref showTableEvent" data-id="tab1fn3" href="#tab1fn3">†</a>
</td>
<td colspan="1" rowspan="1" align="center">23 (4.3)</td>
<td colspan="1" rowspan="1" align="center">80 (5.4)</td>
<td colspan="1" rowspan="1" align="center">297 (5.3)</td>
<td colspan="1" rowspan="1" align="center">177 (7.2)</td>
</tr>
<tr>
<td colspan="1" rowspan="1" align="left">Current smoker, No. (%)</td>
<td colspan="1" rowspan="1" align="center">64 (11.6)</td>
<td colspan="1" rowspan="1" align="center">162 (10.9)</td>
<td colspan="1" rowspan="1" align="center">949 (16.9)</td>
<td colspan="1" rowspan="1" align="center">631 (25.5)</td>
</tr>
<tr>
<td colspan="1" rowspan="1" align="left">History of hypertension, No. (%)</td>
<td colspan="1" rowspan="1" align="center">524 (94.6)</td>
<td colspan="1" rowspan="1" align="center">1404 (94.6)</td>
<td colspan="1" rowspan="1" align="center">5083 (90.4)</td>
<td colspan="1" rowspan="1" align="center">2112 (85.3)</td>
</tr>
<tr>
<td colspan="1" rowspan="1" align="left">History of heart failure, No. (%)</td>
<td colspan="1" rowspan="1" align="center">115 (20.8)</td>
<td colspan="1" rowspan="1" align="center">249 (16.8)</td>
<td colspan="1" rowspan="1" align="center">805 (14.3)</td>
<td colspan="1" rowspan="1" align="center">291 (11.8)</td>
</tr>
<tr>
<td colspan="1" rowspan="1" align="left">Duration of diabetes, y, mean (SD)</td>
<td colspan="1" rowspan="1" align="center">16.8 (8.3)</td>
<td colspan="1" rowspan="1" align="center">15.6 (8.3)</td>
<td colspan="1" rowspan="1" align="center">13.4 (7.6)</td>
<td colspan="1" rowspan="1" align="center">11.9 (7.0)</td>
</tr>
<tr><td colspan="5" rowspan="1" align="left">Drug therapy, No. (%)</td></tr>
<tr>
<td colspan="1" rowspan="1" align="left"> Insulin</td>
<td colspan="1" rowspan="1" align="center">367 (66.3)</td>
<td colspan="1" rowspan="1" align="center">877 (59.0)</td>
<td colspan="1" rowspan="1" align="center">2766 (49.2)</td>
<td colspan="1" rowspan="1" align="center">1085 (43.8)</td>
</tr>
<tr>
<td colspan="1" rowspan="1" align="left"> Sulfonylurea</td>
<td colspan="1" rowspan="1" align="center">181 (32.7)</td>
<td colspan="1" rowspan="1" align="center">577 (38.9)</td>
<td colspan="1" rowspan="1" align="center">2460 (43.7)</td>
<td colspan="1" rowspan="1" align="center">1141 (46.1)</td>
</tr>
<tr>
<td colspan="1" rowspan="1" align="left"> Metformin</td>
<td colspan="1" rowspan="1" align="center">222 (40.1)</td>
<td colspan="1" rowspan="1" align="center">940 (63.3)</td>
<td colspan="1" rowspan="1" align="center">4534 (80.6)</td>
<td colspan="1" rowspan="1" align="center">2129 (86.0)</td>
</tr>
<tr>
<td colspan="1" rowspan="1" align="left"> GLP-1 receptor agonist</td>
<td colspan="1" rowspan="1" align="center">22 (4.0)</td>
<td colspan="1" rowspan="1" align="center">61 (4.1)</td>
<td colspan="1" rowspan="1" align="center">217 (3.9)</td>
<td colspan="1" rowspan="1" align="center">107 (4.3)</td>
</tr>
<tr>
<td colspan="1" rowspan="1" align="left"> DPP-4 inhibitor</td>
<td colspan="1" rowspan="1" align="center">87 (15.7)</td>
<td colspan="1" rowspan="1" align="center">196 (13.2)</td>
<td colspan="1" rowspan="1" align="center">677 (12.0)</td>
<td colspan="1" rowspan="1" align="center">301 (12.2)</td>
</tr>
<tr>
<td colspan="1" rowspan="1" align="left"> Statin</td>
<td colspan="1" rowspan="1" align="center">460 (83.0)</td>
<td colspan="1" rowspan="1" align="center">1130 (76.1)</td>
<td colspan="1" rowspan="1" align="center">4239 (75.4)</td>
<td colspan="1" rowspan="1" align="center">1771 (71.5)</td>
</tr>
<tr>
<td colspan="1" rowspan="1" align="left"> Antithrombotic</td>
<td colspan="1" rowspan="1" align="center">438 (79.1)</td>
<td colspan="1" rowspan="1" align="center">1181 (79.5)</td>
<td colspan="1" rowspan="1" align="center">4142 (73.6)</td>
<td colspan="1" rowspan="1" align="center">1710 (69.0)</td>
</tr>
<tr>
<td colspan="1" rowspan="1" align="left"> RAAS inhibitor</td>
<td colspan="1" rowspan="1" align="center">438 (79.1)</td>
<td colspan="1" rowspan="1" align="center">1217 (82.0)</td>
<td colspan="1" rowspan="1" align="center">4558 (81.0)</td>
<td colspan="1" rowspan="1" align="center">1901 (76.8)</td>
</tr>
<tr>
<td colspan="1" rowspan="1" align="left"> Beta blocker</td>
<td colspan="1" rowspan="1" align="center">363 (65.5)</td>
<td colspan="1" rowspan="1" align="center">912 (61.4)</td>
<td colspan="1" rowspan="1" align="center">3038 (54.0)</td>
<td colspan="1" rowspan="1" align="center">1107 (44.7)</td>
</tr>
<tr>
<td colspan="1" rowspan="1" align="left"> Diuretic</td>
<td colspan="1" rowspan="1" align="center">361 (65.2)</td>
<td colspan="1" rowspan="1" align="center">861 (58.0)</td>
<td colspan="1" rowspan="1" align="center">2453 (43.6)</td>
<td colspan="1" rowspan="1" align="center">815 (32.9)</td>
</tr>
<tr><td colspan="5" rowspan="1" align="left">Microvascular disease history, No. (%)</td></tr>
<tr>
<td colspan="1" rowspan="1" align="left"> Retinopathy</td>
<td colspan="1" rowspan="1" align="center">157 (28.3)</td>
<td colspan="1" rowspan="1" align="center">398 (26.8)</td>
<td colspan="1" rowspan="1" align="center">1177 (20.9)</td>
<td colspan="1" rowspan="1" align="center">397 (16.0)</td>
</tr>
<tr>
<td colspan="1" rowspan="1" align="left"> Nephropathy</td>
<td colspan="1" rowspan="1" align="center">250 (45.1)</td>
<td colspan="1" rowspan="1" align="center">399 (26.9)</td>
<td colspan="1" rowspan="1" align="center">804 (14.3)</td>
<td colspan="1" rowspan="1" align="center">321 (13.0)</td>
</tr>
<tr>
<td colspan="1" rowspan="1" align="left"> Neuropathy</td>
<td colspan="1" rowspan="1" align="center">196 (35.4)</td>
<td colspan="1" rowspan="1" align="center">498 (33.5)</td>
<td colspan="1" rowspan="1" align="center">1734 (30.8)</td>
<td colspan="1" rowspan="1" align="center">682 (27.5)</td>
</tr>
<tr><td colspan="5" rowspan="1" align="left">Atherosclerotic vascular disease history, No. (%)<a class="ref showTableEvent" data-id="tab1fn4" href="#tab1fn4">‡</a>
</td></tr>
<tr>
<td colspan="1" rowspan="1" align="left"> Coronary</td>
<td colspan="1" rowspan="1" align="center">348 (62.8)</td>
<td colspan="1" rowspan="1" align="center">924 (62.2)</td>
<td colspan="1" rowspan="1" align="center">3247 (57.7)</td>
<td colspan="1" rowspan="1" align="center">1202 (48.6)</td>
</tr>
<tr>
<td colspan="1" rowspan="1" align="left"> Cerebrovascular</td>
<td colspan="1" rowspan="1" align="center">132 (23.8)</td>
<td colspan="1" rowspan="1" align="center">325 (21.9)</td>
<td colspan="1" rowspan="1" align="center">1059 (18.8)</td>
<td colspan="1" rowspan="1" align="center">441 (17.8)</td>
</tr>
<tr>
<td colspan="1" rowspan="1" align="left"> Peripheral</td>
<td colspan="1" rowspan="1" align="center">146 (26.4)</td>
<td colspan="1" rowspan="1" align="center">359 (24.2)</td>
<td colspan="1" rowspan="1" align="center">1092 (19.4)</td>
<td colspan="1" rowspan="1" align="center">516 (20.8)</td>
</tr>
<tr>
<td colspan="1" rowspan="1" align="left"> Any</td>
<td colspan="1" rowspan="1" align="center">436 (78.7)</td>
<td colspan="1" rowspan="1" align="center">1146 (77.2)</td>
<td colspan="1" rowspan="1" align="center">4050 (72.0)</td>
<td colspan="1" rowspan="1" align="center">1691 (68.3)</td>
</tr>
<tr>
<td colspan="1" rowspan="1" align="left">CV disease history, No. (%)<a class="ref showTableEvent" data-id="tab1fn5" href="#tab1fn5">§</a>
</td>
<td colspan="1" rowspan="1" align="center">406 (73.3)</td>
<td colspan="1" rowspan="1" align="center">1054 (71.0)</td>
<td colspan="1" rowspan="1" align="center">3654 (65.0)</td>
<td colspan="1" rowspan="1" align="center">1541 (62.2)</td>
</tr>
<tr>
<td colspan="1" rowspan="1" align="left">History of amputation, No. (%)</td>
<td colspan="1" rowspan="1" align="center">29 (5.2)</td>
<td colspan="1" rowspan="1" align="center">55 (3.7)</td>
<td colspan="1" rowspan="1" align="center">105 (1.9)</td>
<td colspan="1" rowspan="1" align="center">49 (2.0)</td>
</tr>
<tr>
<td colspan="1" rowspan="1" align="left">Body mass index, kg/m<sup>2</sup>, mean (SD)</td>
<td colspan="1" rowspan="1" align="center">32.6 (6.1)</td>
<td colspan="1" rowspan="1" align="center">32.2 (6.0)</td>
<td colspan="1" rowspan="1" align="center">31.9 (5.8)</td>
<td colspan="1" rowspan="1" align="center">31.8 (6.2)</td>
</tr>
<tr>
<td colspan="1" rowspan="1" align="left">Systolic BP, mm Hg, mean (SD)</td>
<td colspan="1" rowspan="1" align="center">137.4 (17.8)</td>
<td colspan="1" rowspan="1" align="center">137.5 (16.0)</td>
<td colspan="1" rowspan="1" align="center">136.7 (15.5)</td>
<td colspan="1" rowspan="1" align="center">135.7 (15.7)</td>
</tr>
<tr>
<td colspan="1" rowspan="1" align="left">Diastolic BP, mm Hg, mean (SD)</td>
<td colspan="1" rowspan="1" align="center">74.1 (10.5)</td>
<td colspan="1" rowspan="1" align="center">76.0 (9.9)</td>
<td colspan="1" rowspan="1" align="center">78.0 (9.5)</td>
<td colspan="1" rowspan="1" align="center">78.8 (9.4)</td>
</tr>
<tr>
<td colspan="1" rowspan="1" align="left">Glycohemoglobin, %, mean (SD)</td>
<td colspan="1" rowspan="1" align="center">8.3 (1.0)</td>
<td colspan="1" rowspan="1" align="center">8.2 (0.9)</td>
<td colspan="1" rowspan="1" align="center">8.2 (0.9)</td>
<td colspan="1" rowspan="1" align="center">8.3 (0.9)</td>
</tr>
<tr>
<td colspan="1" rowspan="1" align="left">Total cholesterol, mmol/L, mean (SD)</td>
<td colspan="1" rowspan="1" align="center">4.4 (1.1)</td>
<td colspan="1" rowspan="1" align="center">4.4 (1.2)</td>
<td colspan="1" rowspan="1" align="center">4.3 (1.1)</td>
<td colspan="1" rowspan="1" align="center">4.4 (1.2)</td>
</tr>
<tr>
<td colspan="1" rowspan="1" align="left">Triglycerides, mmol/L, mean (SD)</td>
<td colspan="1" rowspan="1" align="center">2.2 (1.4)</td>
<td colspan="1" rowspan="1" align="center">2.2 (1.3)</td>
<td colspan="1" rowspan="1" align="center">2.0 (1.3)</td>
<td colspan="1" rowspan="1" align="center">2.0 (1.7)</td>
</tr>
<tr>
<td colspan="1" rowspan="1" align="left">HDL-C, mmol/L, mean (SD)</td>
<td colspan="1" rowspan="1" align="center">1.2 (0.3)</td>
<td colspan="1" rowspan="1" align="center">1.2 (0.3)</td>
<td colspan="1" rowspan="1" align="center">1.2 (0.3)</td>
<td colspan="1" rowspan="1" align="center">1.2 (0.3)</td>
</tr>
<tr>
<td colspan="1" rowspan="1" align="left">LDL-C, mmol/L, mean (SD)</td>
<td colspan="1" rowspan="1" align="center">2.2 (0.9)</td>
<td colspan="1" rowspan="1" align="center">2.3 (0.9)</td>
<td colspan="1" rowspan="1" align="center">2.3 (0.9)</td>
<td colspan="1" rowspan="1" align="center">2.4 (0.9)</td>
</tr>
<tr>
<td colspan="1" rowspan="1" align="left">LDL-C/HDL-C ratio, mean (SD)</td>
<td colspan="1" rowspan="1" align="center">2.0 (0.9)</td>
<td colspan="1" rowspan="1" align="center">2.1 (0.9)</td>
<td colspan="1" rowspan="1" align="center">2.0 (0.9)</td>
<td colspan="1" rowspan="1" align="center">2.1 (0.9)</td>
</tr>
<tr>
<td colspan="1" rowspan="1" align="left">eGFR, mL/min/1.73 m<sup>2</sup>, mean (SD)</td>
<td colspan="1" rowspan="1" align="center">38.2 (5.1)</td>
<td colspan="1" rowspan="1" align="center">53.2 (4.2)</td>
<td colspan="1" rowspan="1" align="center">74.6 (8.3)</td>
<td colspan="1" rowspan="1" align="center">103.2 (13.2)</td>
</tr>
<tr>
<td colspan="1" rowspan="1" align="left">UACR, mg/g, median (IQR)</td>
<td colspan="1" rowspan="1" align="center">43.4 (10.3, 310.5)</td>
<td colspan="1" rowspan="1" align="center">17.3 (7.2, 82.1)</td>
<td colspan="1" rowspan="1" align="center">11.2 (6.3, 34.2)</td>
<td colspan="1" rowspan="1" align="center">11.5 (6.8, 31.5)</td>
</tr>
<tr><td colspan="5" rowspan="1" align="left">Albuminuria</td></tr>
<tr>
<td colspan="1" rowspan="1" align="left"> Normoalbuminuria, No. (%)</td>
<td colspan="1" rowspan="1" align="center">241 (44.0)</td>
<td colspan="1" rowspan="1" align="center">888 (60.5)</td>
<td colspan="1" rowspan="1" align="center">4047 (72.8)</td>
<td colspan="1" rowspan="1" align="center">1829 (74.5)</td>
</tr>
<tr>
<td colspan="1" rowspan="1" align="left"> Micro- or macroalbuminuria, No. (%)</td>
<td colspan="1" rowspan="1" align="center">307 (56.0)</td>
<td colspan="1" rowspan="1" align="center">580 (39.5)</td>
<td colspan="1" rowspan="1" align="center">1513 (27.2)</td>
<td colspan="1" rowspan="1" align="center">626 (25.5)</td>
</tr>
</tbody>
</table>
<div class="tableFooter">
<div xmlns:xje="java:com.atypon.publish.util.xml.XslJavaExtension" xmlns:urlutil="java:com.atypon.literatum.customization.UrlUtil" xmlns:fn="http://www.w3.org/2005/xpath-functions" class="footnote"><p xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:oasis="http://www.niso.org/standards/z39-96/ns/oasis-exchange/table" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:bkstg="http://www.atypon.com/backstage-ns">BP
 indicates blood pressure; CV, cardiovascular; DPP-4, dipeptidyl 
peptidase-4; eGFR, estimated glomerular filtration rate; GLP-1, 
glucagon-like peptide-1; HDL-C, high-density lipoprotein cholesterol; 
IQR, interquartile range; LDL-C, low-density lipoprotein cholesterol; 
RAAS, renin angiotensin aldosterone system; SD, standard deviation; and 
UACR, urinary albumin/creatinine ratio.</p></div>
<div xmlns:xje="java:com.atypon.publish.util.xml.XslJavaExtension" xmlns:urlutil="java:com.atypon.literatum.customization.UrlUtil" xmlns:fn="http://www.w3.org/2005/xpath-functions" class="footnote" id="tab1fn2"><p xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:oasis="http://www.niso.org/standards/z39-96/ns/oasis-exchange/table" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:bkstg="http://www.atypon.com/backstage-ns">*Two
 participants had missing eGFR at baseline and were included in the 
overall trial population but not subgroup analyses by baseline eGFR.</p></div>
<div xmlns:xje="java:com.atypon.publish.util.xml.XslJavaExtension" xmlns:urlutil="java:com.atypon.literatum.customization.UrlUtil" xmlns:fn="http://www.w3.org/2005/xpath-functions" class="footnote" id="tab1fn3"><p xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:oasis="http://www.niso.org/standards/z39-96/ns/oasis-exchange/table" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:bkstg="http://www.atypon.com/backstage-ns">†Includes American Indian or Alaska Native, Native Hawaiian or other Pacific Islander, multiple, other, and unknown.</p></div>
<div xmlns:xje="java:com.atypon.publish.util.xml.XslJavaExtension" xmlns:urlutil="java:com.atypon.literatum.customization.UrlUtil" xmlns:fn="http://www.w3.org/2005/xpath-functions" class="footnote" id="tab1fn4"><p xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:oasis="http://www.niso.org/standards/z39-96/ns/oasis-exchange/table" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:bkstg="http://www.atypon.com/backstage-ns">‡Some participants had ≥1 type of atherosclerotic disease.</p></div>
<div xmlns:xje="java:com.atypon.publish.util.xml.XslJavaExtension" xmlns:urlutil="java:com.atypon.literatum.customization.UrlUtil" xmlns:fn="http://www.w3.org/2005/xpath-functions" class="footnote" id="tab1fn5"><p xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:oasis="http://www.niso.org/standards/z39-96/ns/oasis-exchange/table" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:bkstg="http://www.atypon.com/backstage-ns">§As defined in the protocol.</p></div>
</div>
</div>
